$PEN · Penumbra Inc SEC Filings
Position Tracker tracks 2 SEC EDGAR filings for Penumbra Inc ($PEN) from October 29, 2026 through October 29, 2026, including 0 Form 10-K annual reports, 1 Form 10-Q quarterly earnings reports, 1 Form 8-K current event disclosures, and 0 Form 4 insider equity transactions. Select any filing below to read the full AI summary, key financial takeaways, and original SEC.gov document.
$PEN 10-Q — Penumbra Inc
The 10-Q confirms both accelerating thrombectomy growth and margin pressure from SG&A expansion, but the $14.5B Boston Scientific acquisition at $374/share dominates the investm…
$PEN 8-K — Penumbra Inc
Penumbra's results are a footnote to the Boston Scientific acquisition; the withheld guidance and canceled call signal the company is in deal limbo.